ArticleFrontiers in neurology2021

Alemtuzumab in a Large Real-Life Cohort: Interim Baseline Data of the TREAT-MS Study.

Tjalf Ziemssen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.